Gliadel and Drug level decreased - a phase IV clinical study of FDA data

Summary:

Drug level decreased is reported only by a few people who take Gliadel.

The phase IV clinical study analyzes which people take Gliadel and have Drug level decreased. It is created by eHealthMe based on reports of 798 people who have side effects while taking Gliadel from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 22, 2023

798 people reported to have side effects when taking Gliadel.
Among them, 5 people (0.63%) have Drug level decreased.

What is Gliadel?

Gliadel has active ingredients of carmustine. eHealthMe is studying from 800 Gliadel users for its effectiveness, alternative drugs and more.

What is Drug level decreased?

Drug level decreased is found to be associated with 1,061 drugs and 637 conditions by eHealthMe.

Number of Gliadel and Drug level decreased reports submitted per year:

Could Gliadel cause Drug level decreased?

Time on Gliadel when people have Drug level decreased *:

Gender of people who have Drug level decreased when taking Gliadel *:

female: 0.0 %
male: 100 %

Age of people who have Drug level decreased when taking Gliadel *:

Common drugs people take besides Gliadel *:

Common side effects people have besides Drug level decreased *:

Weakness: 4 people, 80.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 60.00%
Stress And Anxiety: 3 people, 60.00%
Postictal State: 3 people, 60.00%
Visual Acuity Reduced (reduced clearness of vision): 3 people, 60.00%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 2 people, 40.00%
Drowsiness: 2 people, 40.00%
Fever: 2 people, 40.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 40.00%
Nuclear Magnetic Resonance Imaging Brain Abnormal: 2 people, 40.00%

Common conditions people have *:

Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 4 people, 80.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Gliadel and have Drug level decreased?

Check whether Drug level decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Drug level decreased and when was it recovered:

Drug level decreased in Gliadel

Expand to all the drugs that have ingredients of carmustine:

Drug level decreased and drugs with ingredients of carmustine

Alternative drugs to, pros and cons of Gliadel:

Gliadel (800 reports)

Drug level decreased treatments and more:

Drug level decreased (9,388 reports)

COVID vaccines that are related to Drug level decreased:

Common drugs associated with Drug level decreased:

All the drugs that are associated with Drug level decreased:

Drug level decreased (1,061 drugs)

Common conditions associated with Drug level decreased:

Crohn's disease: 2,613 reports
Epilepsy: 500 reports
High blood pressure: 240 reports
Seizures: 226 reports
Pain: 159 reports

All the conditions that are associated with Drug level decreased:

Drug level decreased (637 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Gliadel) and Gliadel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.